ACTIVE

PHARMACIE MOLITOR-MEIRLAEN

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

103,5 k €

-29.5% YoY

Gross margin

355,4 k €

-10.6% YoY

Equity

1 M €

-2.1% YoY

Workforce

3,0 ETP

-3.2% YoY

What does PHARMACIE MOLITOR-MEIRLAEN do?

PHARMACIE MOLITOR-MEIRLAEN is a Private limited company incorporated in 2005. Its registered office is in Viroinval. It employs on average 3,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0876.905.635

Incorporation

25/10/2005

Legal form

Private limited company

Registered office

Rue Jean-Chot, Olloy 72
5670 Viroinval · WallonieSee on map

Contributed capital

30 000,00 €

Latest accounts

31/12/2025

Average workforce

3,0 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	355,4 k €	-10.6%	397,7 k €	+12.8%	352,4 k €	-7.6%	381,3 k €	-1.6%	387,4 k €	+21.2%	319,8 k €	+1.7%	314,5 k €	+21.0%	259,9 k €	+7.8%	241,1 k €	-14.2%	280,9 k €	+5.1%	267,3 k €	+21.3%	220,3 k €	+11.7%	197,3 k €	+9.6%	180,1 k €	-10.5%	201,1 k €	+25.4%	160,4 k €	-5.8%	170,3 k €	+3.9%	163,9 k €	-10.2%	182,5 k €	+41.9%	128,6 k €
EBITDA	244,4 k €	-16.0%	290,8 k €	+15.3%	252,2 k €	-13.9%	292,9 k €	-2.7%	301 k €	+34.4%	224 k €	-3.4%	232 k €	+68.0%	138,1 k €	-1.3%	139,9 k €	-35.5%	216,8 k €	+7.8%	201,1 k €	+31.7%	152,7 k €	-1.0%	154,2 k €	+35.8%	113,5 k €	-14.7%	133,1 k €	+4.9%	126,9 k €	-10.5%	141,8 k €	+0.2%	141,4 k €	-13.6%	163,6 k €	+33.2%	122,9 k €
Operating result	154,8 k €	-21.9%	198,2 k €	+14.3%	173,5 k €	-15.0%	204,1 k €	-2.8%	210,1 k €	+55.9%	134,7 k €	-3.7%	139,8 k €	+241%	41 k €	-23.8%	53,8 k €	-61.9%	141,2 k €	+37.0%	103,1 k €	+74.6%	59 k €	-19.5%	73,3 k €	+32.2%	55,4 k €	-25.7%	74,6 k €	+12.1%	66,5 k €	-21.0%	84,2 k €	-9.0%	92,5 k €	-22.5%	119,3 k €	+81.1%	65,9 k €
Net result	103,5 k €	-29.5%	146,8 k €	+8.2%	135,7 k €	-14.8%	159,3 k €	-5.1%	168 k €	+35.8%	123,7 k €	-0.3%	124,1 k €	+137%	52,4 k €	-8.7%	57,4 k €	-46.2%	106,8 k €	+74.0%	61,4 k €	+203%	20,3 k €	-56.7%	46,8 k €	+72.5%	27,1 k €	-27.1%	37,2 k €	+13.9%	32,6 k €	-33.7%	49,2 k €	-18.5%	60,4 k €	-25.4%	81 k €	+93.3%	41,9 k €
Balance sheet
Equity	1 M €	-2.1%	1,1 M €	+9.7%	969,2 k €	+8.5%	892,9 k €	+3.6%	861,5 k €	+10.6%	778,9 k €	+15.0%	677,5 k €	+22.3%	554,1 k €	+10.3%	502,4 k €	+12.7%	445,7 k €	+31.2%	339,6 k €	+25.0%	271,7 k €	+8.1%	251,5 k €	+8.2%	232,5 k €	+11.1%	209,2 k €	-23.1%	272 k €	+11.9%	243 k €	+23.1%	197,4 k €	+40.4%	140,6 k €	+112%	66,3 k €
Total assets	2,7 M €	+4.1%	2,6 M €	+7.7%	2,4 M €	+2.6%	2,4 M €	+10.5%	2,1 M €	+16.9%	1,8 M €	+1.6%	1,8 M €	+13.0%	1,6 M €	+2.3%	1,6 M €	+1.5%	1,5 M €	+6.2%	1,4 M €	-0.3%	1,4 M €	+33.0%	1,1 M €	+38.1%	786,9 k €	+11.0%	709,1 k €	+2.7%	690,4 k €	-2.0%	704,7 k €	+8.7%	648,4 k €	+0.9%	642,6 k €	+5.2%	610,9 k €
Cash	1,1 M €	-10.9%	1,2 M €	+26.2%	959 k €	+5.5%	909 k €	+22.6%	741,4 k €	+81.5%	408,6 k €	+19.6%	341,5 k €	+289%	87,8 k €	-49.2%	172,9 k €	-18.6%	212,3 k €	+16.5%	182,2 k €	+0.7%	180,8 k €	+146%	73,6 k €	-18.6%	90,4 k €	-22.4%	116,6 k €	+60.9%	72,5 k €	+1.0%	71,7 k €	+54.2%	46,5 k €	-49.3%	91,8 k €	-12.0%	104,3 k €
Debts	1,6 M €	+8.4%	1,5 M €	+5.5%	1,4 M €	-1.8%	1,4 M €	+14.9%	1,3 M €	+21.6%	1 M €	-6.4%	1,1 M €	+9.3%	1 M €	-2.5%	1 M €	-3.2%	1,1 M €	-1.6%	1,1 M €	-6.2%	1,2 M €	+41.2%	821,7 k €	+59.4%	515,5 k €	+10.1%	468,2 k €	+13.7%	411,7 k €	-9.9%	457,1 k €	+2.0%	447,9 k €	-10.3%	499,3 k €	-6.3%	532,7 k €
Other
Workforce	3,0 ETP	-3.2%	3,1 ETP	+3.3%	3,0 ETP	0.0%	3,0 ETP	0.0%	3,0 ETP	-6.3%	3,2 ETP	+3.2%	3,1 ETP	-22.5%	4,0 ETP	+5.3%	3,8 ETP	+5.6%	3,6 ETP	+16.1%	3,1 ETP	+55.0%	2,0 ETP	-13.0%	2,3 ETP	-11.5%	2,6 ETP	+73.3%	1,5 ETP	+25.0%	1,2 ETP	0.0%	1,2 ETP	+50.0%	0,8 ETP	+14.3%	0,7 ETP	+250%	0,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Marie Pierre MEIRLAEN

Director

Active

Michaël MOLITOR

Director

Active

Ended mandates

Michaël MOLITOR

Manager · since 07 novembre 2005

Ended

Marie-Pierre MEIRLAEN

Director

Ended

Michaël MOLITOR

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMA GONRIEUX● Active	0697.833.935

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	30/08/2025	30/08/2024	31/08/2023	29/08/2022	27/08/2021
General meeting	31/07/2026	31/07/2025	31/07/2024	31/07/2023	31/07/2022	31/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	31/07/2026	28/08/2026	French	PDF
Abridged model	31/12/2024	31/07/2025	30/08/2025	French	PDF
Abridged model	31/12/2023	31/07/2024	30/08/2024	French	PDF
Abridged model	31/12/2022	31/07/2023	31/08/2023	French	PDF
Abridged model	31/12/2021	31/07/2022	29/08/2022	French	PDF
Abridged model	31/12/2020	31/07/2021	27/08/2021	French	PDF
Abridged model	31/12/2019	25/08/2020	21/10/2020	French	PDF
Abridged model	31/12/2018	31/07/2019	29/08/2019	French	PDF
Abridged model	31/12/2017	28/08/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	31/08/2017	31/08/2017	French	PDF
Abridged model	31/12/2015	31/07/2016	25/08/2016	French	PDF
Abridged model	31/12/2014	24/07/2015	30/07/2015	French	PDF
Abridged model	31/12/2013	31/07/2014	04/08/2014	French	PDF
Abridged model	31/12/2012	31/07/2013	12/08/2013	French	PDF
Abridged model	31/12/2011	16/07/2012	16/08/2012	French	PDF
Abridged model	31/12/2010	18/07/2011	28/07/2011	French	PDF
Abridged model	31/12/2009	31/07/2010	27/08/2010	French	PDF
Abridged model	31/12/2008	30/06/2009	27/08/2009	French	PDF
Abridged model	31/12/2007	30/06/2008	30/07/2008	French	PDF
Abridged model	31/12/2006	04/06/2007	20/06/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 3 ended

Active mandates

Marie Pierre MEIRLAEN

Director

Active

Michaël MOLITOR

Director

Active

Ended mandates

Michaël MOLITOR

Manager · since 07 novembre 2005

Ended

Marie-Pierre MEIRLAEN

Director

Ended

Michaël MOLITOR

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates05/01/2024
OBJET - DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates02/04/2010
DEMISSIONS, NOMINATIONS
PDF
Other07/11/2005
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025103,5 k €↓
2024
Annual accounts 2024146,8 k €↑
2023
Annual accounts 2023135,7 k €↓
2022
Annual accounts 2022159,3 k €↓
2021
Annual accounts 2021168 k €↑
2020
Annual accounts 2020123,7 k €↓
2019
Annual accounts 2019124,1 k €↑
2018
Annual accounts 201852,4 k €↓
2017
Annual accounts 201757,4 k €↓
2016
Annual accounts 2016106,8 k €↑
2015
Annual accounts 201561,4 k €↑
2014
Annual accounts 201420,3 k €↓
2013
Annual accounts 201346,8 k €↑
2012
Annual accounts 201227,1 k €↓
2011
Annual accounts 201137,2 k €↑
2010
Annual accounts 201032,6 k €↓
2009
Annual accounts 200949,2 k €↓
2008
Annual accounts 200860,4 k €↓
2007
Annual accounts 200781 k €↑
2006
Annual accounts 200641,9 k €
25/10/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMACIE MOLITOR-MEIRLAEN

Overview

What does PHARMACIE MOLITOR-MEIRLAEN do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline